MyAverix Finance MyAverix Finance

HM

Biotest AG Vorzugsaktien (VZ) (BIO3)

Biotest AG Vorzugsaktien (VZ) (BIO3) is listed on HM. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-22

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for BIO3

P/E ratio
18.00

Biotest AG Vorzugsaktien (VZ) (BIO3) — FAQ

What is BIO3's P/E ratio?

The price-to-earnings (P/E) ratio for Biotest AG Vorzugsaktien (VZ) (BIO3) is 18.00 (data as of 2026-03-22).

Does Biotest AG Vorzugsaktien (VZ) pay a dividend?

Dividend yield is not available in the current snapshot for Biotest AG Vorzugsaktien (VZ) (BIO3). Check the MyAverix Finance app for the latest dividend data.

What exchange is BIO3 listed on?

BIO3 is listed on HM.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play